1. Abbona G, Papotti M, Viberti L, Macri L, Stella A, Bussolati G (1998) Chromogranin A gene expression in non-small cell lung carcinomas. J Pathol 186:151–156
2. Atasoy P, Ensari A, Demirci S, Kursun N (2003) Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance. Tumori 89:49–53
3. Berruti A, Mosca A, Tucci M, Terrone C, Torta M, Tarabuzzi R, Russo L, Cracco C, Bollito E, Scarpa RM, Angeli A, Dogliotti L (2005) Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. Endocr Relate Cancer 12:107–115
4. Blumenfeld W, Chandhoke DK, Sagerman P, Turi GK (1996) Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study. Arch Pathol Lab Med 120:478–481
5. Bollito E, Berruti A, Bellina M, Mosca A, Leonardo E, Tarabuzzi R, Cappia S, Ari MM, Tampellini M, Fontana D, Gubetta L, Angeli A, Dogliotti L (2001) Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma. Ann Oncol 12S:159–164